In the latest trading session, 0.46 million Sana Biotechnology Inc (NASDAQ:SANA) shares changed hands as the company’s beta touched 1.61. With the company’s most recent per share price at $2.88 changed hands at -$0.13 or -4.49% at last look, the market valuation stands at $641.90M. SANA’s current price is a discount, trading about -316.67% off its 52-week high of $12.00. The share price had its 52-week low at $1.52, which suggests the last value was 47.22% up since then.
Analysts gave the Sana Biotechnology Inc (SANA) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.57. If we narrow down to specifics, the data shows that 0 out of 2 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended SANA as a Hold, 2 felt it is a Buy and 0 rated the stock as Underweight. Sana Biotechnology Inc’s EPS for the current quarter is expected to be -0.26.
Sana Biotechnology Inc (NASDAQ:SANA) trade information
Instantly SANA was in red as seen in intraday trades today. With action -9.02%, the performance over the past five days has been red. The company’s shares are showing year-to-date upside of 76.38%, with the 5-day performance at -9.02% in the red. However, in the 30-day time frame, Sana Biotechnology Inc (NASDAQ:SANA) is -17.62% down.
The consensus price target for the stock as assigned by Wall Street analysts is 8, meaning bulls need an upside of 64.0% from its recent market value. According to analyst projections, SANA’s forecast low is 8 with 8 as the target high. To hit the forecast high, the stock’s price needs a -177.78% plunge from its current level, while the stock would need to soar -177.78% for it to hit the projected low.
Sana Biotechnology Inc (SANA) estimates and forecasts
According to analysts, the company will likely register a growth in its current quarter sales, forecast at 0.00%. The estimates for the next quarter sales put growth at 0.00%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -83.13%. The 2025 estimates are for Sana Biotechnology Inc earnings to increase by 17.68%, but the outlook for the next 5-year period is at 17.56% per year.
Sana Biotechnology Inc (NASDAQ:SANA)’s Major holders
FLAGSHIP PIONEERING INC. holds the second largest percentage of outstanding shares, with 10.6645% or 25.0 million shares worth $136.51 million as of 2024-06-30.
Among Mutual Funds, the top two as of Dec 31, 2024 were Fidelity Growth Company Fund and Smallcap World Fund. With 9.57 shares estimated at $27.41 million under it, the former controlled 4.28% of total outstanding shares. On the other hand, Smallcap World Fund held about 2.63% of the shares, roughly 5.88 shares worth around $16.84 million.
